Boehringer boosts ADC portfolio with NBE Therapeutics R&D center
03 Apr 2025 //
GLOBENEWSWIRE
NBE- Commences First Clinical Study of Anti-ROR1 Antibody-Drug Conjugate
26 Oct 2020 //
PRNEWSWIRE
03 Apr 2025 //
GLOBENEWSWIRE
26 Oct 2020 //
PRNEWSWIRE